Properties (32)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
corporation
|
| gptkbp:acquisition |
Acquired_Avanir_Pharmaceuticals_in_2014
Acquired_Astex_Pharmaceuticals_in_2013 |
| gptkbp:awards |
Best Companies to Work For
Innovation in Pharmaceuticals Award |
| gptkbp:CEO |
gptkb:Taro_Iwamoto
Dr._H._Otsuka_(founder) |
| gptkbp:employees |
over 40,000
|
| gptkbp:founded |
1964
|
| gptkbp:founder |
Dr._H._Otsuka
|
| gptkbp:global_presence |
operates in over 20 countries
|
| gptkbp:headquarters |
gptkb:Tokyo,_Japan
|
| https://www.w3.org/2000/01/rdf-schema#label |
the Otsuka Group
|
| gptkbp:industry |
pharmaceuticals
nutritional products |
| gptkbp:partnerships |
Partnership_with_the_University_of_Tokyo
Partnership_with_the_University_of_California |
| gptkbp:philanthropy |
gptkb:Otsuka_Foundation
|
| gptkbp:products |
Nutritional supplements
Vasopressin Abilify |
| gptkbp:research_focus |
mental health
oncology cardiovascular diseases |
| gptkbp:revenue |
over $10 billion
|
| gptkbp:subsidiary |
gptkb:Otsuka_Pharmaceutical_Co.,_Ltd.
gptkb:Otsuka_America_Pharmaceutical,_Inc. Otsuka_Pharmaceutical_Europe_Ltd. |
| gptkbp:sustainability |
commitment to social responsibility
focus on environmental responsibility initiatives for health and wellness |
| gptkbp:website |
www.otsuka.com
|